ICCM Icecure Medical
Company Analysis
Latest News
🟢 Icecure Medical is trading 5% up in pre-market with no clear catalyst identified
Icecure Medical is trading 5.26% higher at $1.70 in pre-market on October 1, 2026; no clear company-specific catalyst has been identified. - Shares closed at...
🟢 Icecure Medical is trading 10.22% up in after-hours trading
Icecure Medical is trading at $1.78, up 10.22% in after-hours trading, with no clear company-specific catalyst identified for the September 30, 2026 rise. -...
🟢 Icecure Medical is trading 13.2% up; no clear catalyst identified
Icecure Medical is trading 13.21% higher at $1.80 on September 30, 2026, with no clear catalyst identified. - No fresh company-specific announcement or clearly...
🟢 Icecure Medical is trading 7% up today
Icecure Medical is trading at $1.71, up 7.23%, in an unexplained intraday move. - No fresh company-specific announcement explaining the September 30 move was...
🟢 Icecure Medical is trading 5% up in pre-market
Icecure Medical is trading 5.03% up at $1.67 before the September 30, 2026 session, with no fresh company-specific announcement identified to explain the...
🟢 Icecure Medical is trading 5% up in after-hours trading with no clear company-specific catalyst identified
Icecure Medical is trading at $1.67, up +5.03% after-hours; no clear company-specific announcement explaining the rise was found. - The latest identified...
🔴 Icecure Medical is trading 5.8% down today as oil climbed and Treasury yields rose
Icecure Medical is trading at $1.63, down 5.78%, amid broad risk-off pressure on September 28 after President Trump rejected an Iranian proposal. - Reuters...
🟢 Icecure Medical is trading 10.4% up in pre-market — catalyst remains unconfirmed
Icecure Medical is trading 10.4% higher at $1.91, with no confirmed catalyst identified. - It closed at $1.73 on September 24, 2026. - No new company-specific...
🔴 Icecure Medical is trading 5.35% down today amid elevated Treasury yields and inflation concerns
Icecure Medical is trading 5.35% down now at $1.77 amid elevated Treasury yields and renewed inflation concerns. - No new company-specific announcement was...
🔴 Icecure Medical is trading 5.1% down today amid rising Treasury yields
Icecure Medical is trading at $1.85, down 5.13%, amid broad risk-asset pressure from rising Treasury yields and renewed inflation concerns. - No new...
🟢 Icecure Medical is trading 7.18% up in pre-market amid continued risk-on sentiment
Icecure Medical is trading 7.18% up at $2.09 alongside the broader September 21, 2026 equity rally. - No new company-specific announcement was identified...
🟢 Icecure Medical is trading 5.64% up in after-hours trading amid a broad market rally
Icecure Medical is trading 5.64% up at $2.06 in after-hours trading amid a strong September 21, 2026 market rally led by technology and growth stocks,...
🟢 Icecure Medical is trading 5.36% up today amid falling oil prices and lower Treasury yields
Icecure Medical is trading 5.36% up at $2.06 as U.S. equities, technology stocks, and cryptocurrency rally on falling oil prices and lower Treasury yields. -...
🟢 Icecure Medical is trading 7.64% up in pre-market today amid broad risk-on sentiment
Icecure Medical is trading at $2.11, up +7.64%, most likely amid broad risk-on sentiment as major U.S. indices rise more than 0.5%. - No new company-specific...
🟢 Icecure Medical is trading 6.53% up in pre-market as Nasdaq futures rise approximately 0.68%
Icecure Medical is trading 6.53% up at $2.12 in pre-market, apparently driven mainly by constructive broader-market sentiment. - No new company-specific...
🟢 Icecure Medical is trading 5.59% up in pre-market amid gains in S&P 500 and Nasdaq futures
Icecure Medical is trading at $2.18 (+5.59%) in pre-market amid broader risk-on sentiment. - No new company-specific announcement or overnight filing was...
🔴 Icecure Medical is trading 5% down today
Icecure Medical is trading 5.43% down now at $2.09, reversing from its $2.21 close on September 11, 2026, as the immediate catalyst remains unclear. - The...
IceCure Cracks Open China's Fast-Growing Cancer Device Market — But Can a $7 Million Company Actually Capitalize?
Shares of IceCure Medical jumped +10% to $2.43 on the heels of a regulatory green light from China's drug authority, defying a soft broader market and...
🟢 Icecure Medical is trading 10% up in pre-market after China’s NMPA approved ProSense for commercialization
Icecure Medical is trading at $2.43, up 9.99%, after China’s NMPA approved ProSense and associated cryoprobes for commercialization. - The Class III...
🟢 Icecure Medical is trading 6% up today after China approved ProSense for commercialization
Icecure Medical is trading at $2.27 (+6.07%) after receiving China NMPA Class III approval for its ProSense cryoablation system and associated cryoprobes. -...